1 Study Coverage
1.1 Valsartan Product Introduction
1.2 Global Valsartan Outlook 2021 VS 2025 VS 2031
1.2.1 Global Valsartan Sales in US$ Million for the Year 2025-2031
1.2.2 Global Valsartan Sales in Volume for the Year 2025-2031
1.3 United States Valsartan Outlook 2021 VS 2025 VS 2031
1.3.1 United States Valsartan Sales in US$ Million for the Year 2025-2031
1.3.2 United States Valsartan Sales in Volume for the Year 2025-2031
1.4 Valsartan Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.4.1 The Market Share of United States Valsartan in Global, 2021 VS 2025 VS 2031
1.4.2 The Growth Rate of Valsartan Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.5 Valsartan Market Dynamics
1.5.1 Valsartan Industry Trends
1.5.2 Valsartan Market Drivers
1.5.3 Valsartan Market Challenges
1.5.4 Valsartan Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Valsartan Market Segment by Type
2.1.1 40 mg Tablets
2.1.2 80 mg Tablets
2.1.3 160 mg Tablets
2.1.4 320 mg Tablets
2.2 Global Valsartan Market Size by Type
2.2.1 Global Valsartan Sales in Value, by Type (2021, 2025 & 2031)
2.2.2 Global Valsartan Sales in Volume, by Type (2021, 2025 & 2031)
2.2.3 Global Valsartan Average Selling Price (ASP) by Type (2021, 2025 & 2031)
2.3 United States Valsartan Market Size by Type
2.3.1 United States Valsartan Sales in Value, by Type (2021, 2025 & 2031)
2.3.2 United States Valsartan Sales in Volume, by Type (2021, 2025 & 2031)
2.3.3 United States Valsartan Average Selling Price (ASP) by Type (2021, 2025 & 2031)
3 Market by Application
3.1 Valsartan Market Segment by Application
3.1.1 Hypertension
3.1.2 Heart Failure
3.1.3 Heart Attack
3.2 Global Valsartan Market Size by Application
3.2.1 Global Valsartan Sales in Value, by Application (2021, 2025 & 2031)
3.2.2 Global Valsartan Sales in Volume, by Application (2021, 2025 & 2031)
3.3.3 Global Valsartan Average Selling Price (ASP) by Application (2021, 2025 & 2031)
3.3 United States Valsartan Market Size by Application
3.3.1 United States Valsartan Sales in Value, by Application (2021, 2025 & 2031)
3.3.2 United States Valsartan Sales in Volume, by Application (2021, 2025 & 2031)
3.3.3 United States Valsartan Average Selling Price (ASP) by Application (2021, 2025 & 2031)
4 Global Valsartan Competitor Landscape by Company
4.1 Global Valsartan Market Size by Company
4.1.1 Top Global Valsartan Manufacturers Ranked by Revenue (2025)
4.1.2 Global Valsartan Revenue by Manufacturer (2021-2025)
4.1.3 Global Valsartan Sales by Manufacturer (2021-2025)
4.1.4 Global Valsartan Price by Manufacturer (2021-2025)
4.2 Global Valsartan Concentration Ratio (CR)
4.2.1 Valsartan Market Concentration Ratio (CR) (2021-2025)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Valsartan in 2021
4.2.3 Global Valsartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Valsartan Manufacturing Base Distribution, Product Type
4.3.1 Global Valsartan Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Valsartan Product Type
4.3.3 Date of International Manufacturers Enter into Valsartan Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Valsartan Market Size by Company
4.5.1 Top Valsartan Players in United States, Ranked by Revenue (2025)
4.5.2 United States Valsartan Revenue by Players (2023, 2024 & 2025)
4.5.3 United States Valsartan Sales by Players (2023, 2024 & 2025)
5 Global Valsartan Market Size by Region
5.1 Global Valsartan Market Size by Region: 2021 VS 2025 VS 2031
5.2 Global Valsartan Market Size in Volume by Region (2025-2031)
5.2.1 Global Valsartan Sales in Volume by Region: 2021-2025
5.2.2 Global Valsartan Sales in Volume Forecast by Region (2025-2031)
5.3 Global Valsartan Market Size in Value by Region (2025-2031)
5.3.1 Global Valsartan Sales in Value by Region: 2021-2025
5.3.2 Global Valsartan Sales in Value by Region: 2025-2031
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Valsartan Market Size YoY Growth 2025-2031
6.1.2 North America Valsartan Market Facts & Figures by Country (2021, 2025 & 2031)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Valsartan Market Size YoY Growth 2025-2031
6.2.2 Asia-Pacific Valsartan Market Facts & Figures by Region (2021, 2025 & 2031)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Valsartan Market Size YoY Growth 2025-2031
6.3.2 Europe Valsartan Market Facts & Figures by Country (2021, 2025 & 2031)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Valsartan Market Size YoY Growth 2025-2031
6.4.2 Latin America Valsartan Market Facts & Figures by Country (2021, 2025 & 2031)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Valsartan Market Size YoY Growth 2025-2031
6.5.2 Middle East and Africa Valsartan Market Facts & Figures by Country (2021, 2025 & 2031)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Corporation Information
7.1.2 Novartis Description and Business Overview
7.1.3 Novartis Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.1.4 Novartis Valsartan Products Offered
7.1.5 Novartis Recent Development
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Corporation Information
7.2.2 Sun Pharmaceutical Description and Business Overview
7.2.3 Sun Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.2.4 Sun Pharmaceutical Valsartan Products Offered
7.2.5 Sun Pharmaceutical Recent Development
7.3 Teva
7.3.1 Teva Corporation Information
7.3.2 Teva Description and Business Overview
7.3.3 Teva Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.3.4 Teva Valsartan Products Offered
7.3.5 Teva Recent Development
7.4 Mylan
7.4.1 Mylan Corporation Information
7.4.2 Mylan Description and Business Overview
7.4.3 Mylan Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.4.4 Mylan Valsartan Products Offered
7.4.5 Mylan Recent Development
7.5 Alembic Pharmaceuticals
7.5.1 Alembic Pharmaceuticals Corporation Information
7.5.2 Alembic Pharmaceuticals Description and Business Overview
7.5.3 Alembic Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.5.4 Alembic Pharmaceuticals Valsartan Products Offered
7.5.5 Alembic Pharmaceuticals Recent Development
7.6 Lupin
7.6.1 Lupin Corporation Information
7.6.2 Lupin Description and Business Overview
7.6.3 Lupin Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.6.4 Lupin Valsartan Products Offered
7.6.5 Lupin Recent Development
7.7 Aurobindo Pharma
7.7.1 Aurobindo Pharma Corporation Information
7.7.2 Aurobindo Pharma Description and Business Overview
7.7.3 Aurobindo Pharma Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.7.4 Aurobindo Pharma Valsartan Products Offered
7.7.5 Aurobindo Pharma Recent Development
7.8 Macleods Pharmaceuticals
7.8.1 Macleods Pharmaceuticals Corporation Information
7.8.2 Macleods Pharmaceuticals Description and Business Overview
7.8.3 Macleods Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.8.4 Macleods Pharmaceuticals Valsartan Products Offered
7.8.5 Macleods Pharmaceuticals Recent Development
7.9 HETERO
7.9.1 HETERO Corporation Information
7.9.2 HETERO Description and Business Overview
7.9.3 HETERO Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.9.4 HETERO Valsartan Products Offered
7.9.5 HETERO Recent Development
7.10 Torrent Pharmaceuticals
7.10.1 Torrent Pharmaceuticals Corporation Information
7.10.2 Torrent Pharmaceuticals Description and Business Overview
7.10.3 Torrent Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.10.4 Torrent Pharmaceuticals Valsartan Products Offered
7.10.5 Torrent Pharmaceuticals Recent Development
7.11 Huaren Pharmaceutical
7.11.1 Huaren Pharmaceutical Corporation Information
7.11.2 Huaren Pharmaceutical Description and Business Overview
7.11.3 Huaren Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.11.4 Huaren Pharmaceutical Valsartan Products Offered
7.11.5 Huaren Pharmaceutical Recent Development
7.12 Jubilant Pharma
7.12.1 Jubilant Pharma Corporation Information
7.12.2 Jubilant Pharma Description and Business Overview
7.12.3 Jubilant Pharma Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.12.4 Jubilant Pharma Products Offered
7.12.5 Jubilant Pharma Recent Development
7.13 Amneal Pharmaceuticals
7.13.1 Amneal Pharmaceuticals Corporation Information
7.13.2 Amneal Pharmaceuticals Description and Business Overview
7.13.3 Amneal Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.13.4 Amneal Pharmaceuticals Products Offered
7.13.5 Amneal Pharmaceuticals Recent Development
7.14 Zhejiang Huahai Pharmaceutical
7.14.1 Zhejiang Huahai Pharmaceutical Corporation Information
7.14.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
7.14.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.14.4 Zhejiang Huahai Pharmaceutical Products Offered
7.14.5 Zhejiang Huahai Pharmaceutical Recent Development
7.15 Square Pharmaceuticals
7.15.1 Square Pharmaceuticals Corporation Information
7.15.2 Square Pharmaceuticals Description and Business Overview
7.15.3 Square Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.15.4 Square Pharmaceuticals Products Offered
7.15.5 Square Pharmaceuticals Recent Development
7.16 Unichem Laboratories
7.16.1 Unichem Laboratories Corporation Information
7.16.2 Unichem Laboratories Description and Business Overview
7.16.3 Unichem Laboratories Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.16.4 Unichem Laboratories Products Offered
7.16.5 Unichem Laboratories Recent Development
7.17 LG Life Sciences
7.17.1 LG Life Sciences Corporation Information
7.17.2 LG Life Sciences Description and Business Overview
7.17.3 LG Life Sciences Valsartan Sales, Revenue and Gross Margin (2021-2025)
7.17.4 LG Life Sciences Products Offered
7.17.5 LG Life Sciences Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Valsartan Industry Chain Analysis
8.2 Valsartan Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Valsartan Distributors
8.3 Valsartan Production Mode & Process
8.4 Valsartan Sales and Marketing
8.4.1 Valsartan Sales Channels
8.4.2 Valsartan Distributors
8.5 Valsartan Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Valsartan CAGR in Value, United States VS Global, 2021 VS 2025 VS 2031
Table 2. Valsartan Market Trends
Table 3. Valsartan Market Drivers
Table 4. Valsartan Market Challenges
Table 5. Valsartan Market Restraints
Table 6. Global Valsartan Sales by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 7. United States Valsartan Sales by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 8. Global Valsartan Sales by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 9. United States Valsartan Sales by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 10. Top Valsartan Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Valsartan Revenue by Manufacturer, (US$ Million), 2021-2025
Table 12. Global Valsartan Revenue Share by Manufacturer, 2021-2025
Table 13. Global Valsartan Sales by Manufacturer, (K Units), 2021-2025
Table 14. Global Valsartan Sales Share by Manufacturer, 2021-2025
Table 15. Global Valsartan Price by Manufacturer (2021-2025) & (US$/Unit)
Table 16. Global Valsartan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Valsartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan as of 2021)
Table 18. Top Players of Valsartan in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Valsartan Product Type
Table 20. Date of International Manufacturers Enter into Valsartan Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Valsartan Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Valsartan Revenue by Players, (US$ Million), 2023, 2024 & 2025
Table 24. United States Valsartan Revenue Share by Players, 2023, 2024 & 2025
Table 25. United States Valsartan Sales by Players, (K Units), 2023, 2024 & 2025
Table 26. United States Valsartan Sales Share by Players, 2023, 2024 & 2025
Table 27. Global Valsartan Market Size by Region (US$ Million): 2021 VS 2025 VS 2031
Table 28. Global Valsartan Sales in Volume by Region (2021-2025) & (K Units)
Table 29. Global Valsartan Sales in Volume Forecast by Region (2025-2031) & (K Units)
Table 30. Global Valsartan Sales in Value by Region (2021-2025) & (US$ Million)
Table 31. Global Valsartan Sales in Value Forecast by Region (2025-2031) & (US$ Million)
Table 32. North America Valsartan Sales in Volume by Country (2025-2031) & (K Units)
Table 33. North America Valsartan Sales in Value by Country (2025-2031) & (US$ Million)
Table 34. Asia Pacific Valsartan Sales in Volume by Region (2025-2031) & (K Units)
Table 35. Asia Pacific Valsartan Sales in Value by Region (2025-2031) & (US$ Million)
Table 36. Europe Valsartan Sales in Volume by Country (2025-2031) & (K Units)
Table 37. Europe Valsartan Sales in Value by Country (2025-2031) & (US$ Million)
Table 38. Latin America Valsartan Sales in Volume by Country (2025-2031) & (K Units)
Table 39. Latin Americaa Valsartan Sales in Value by Country (2025-2031) & (US$ Million)
Table 40. Middle East and Africa Valsartan Sales in Volume by Country (2025-2031) & (K Units)
Table 41. Middle East and Africa Valsartan Sales in Value by Country (2025-2031) & (US$ Million)
Table 42. Novartis Corporation Information
Table 43. Novartis Description and Business Overview
Table 44. Novartis Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 45. Novartis Valsartan Product
Table 46. Novartis Recent Development
Table 47. Sun Pharmaceutical Corporation Information
Table 48. Sun Pharmaceutical Description and Business Overview
Table 49. Sun Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 50. Sun Pharmaceutical Product
Table 51. Sun Pharmaceutical Recent Development
Table 52. Teva Corporation Information
Table 53. Teva Description and Business Overview
Table 54. Teva Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 55. Teva Product
Table 56. Teva Recent Development
Table 57. Mylan Corporation Information
Table 58. Mylan Description and Business Overview
Table 59. Mylan Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 60. Mylan Product
Table 61. Mylan Recent Development
Table 62. Alembic Pharmaceuticals Corporation Information
Table 63. Alembic Pharmaceuticals Description and Business Overview
Table 64. Alembic Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 65. Alembic Pharmaceuticals Product
Table 66. Alembic Pharmaceuticals Recent Development
Table 67. Lupin Corporation Information
Table 68. Lupin Description and Business Overview
Table 69. Lupin Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 70. Lupin Product
Table 71. Lupin Recent Development
Table 72. Aurobindo Pharma Corporation Information
Table 73. Aurobindo Pharma Description and Business Overview
Table 74. Aurobindo Pharma Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 75. Aurobindo Pharma Product
Table 76. Aurobindo Pharma Recent Development
Table 77. Macleods Pharmaceuticals Corporation Information
Table 78. Macleods Pharmaceuticals Description and Business Overview
Table 79. Macleods Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 80. Macleods Pharmaceuticals Product
Table 81. Macleods Pharmaceuticals Recent Development
Table 82. HETERO Corporation Information
Table 83. HETERO Description and Business Overview
Table 84. HETERO Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 85. HETERO Product
Table 86. HETERO Recent Development
Table 87. Torrent Pharmaceuticals Corporation Information
Table 88. Torrent Pharmaceuticals Description and Business Overview
Table 89. Torrent Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 90. Torrent Pharmaceuticals Product
Table 91. Torrent Pharmaceuticals Recent Development
Table 92. Huaren Pharmaceutical Corporation Information
Table 93. Huaren Pharmaceutical Description and Business Overview
Table 94. Huaren Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 95. Huaren Pharmaceutical Product
Table 96. Huaren Pharmaceutical Recent Development
Table 97. Jubilant Pharma Corporation Information
Table 98. Jubilant Pharma Description and Business Overview
Table 99. Jubilant Pharma Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 100. Jubilant Pharma Product
Table 101. Jubilant Pharma Recent Development
Table 102. Amneal Pharmaceuticals Corporation Information
Table 103. Amneal Pharmaceuticals Description and Business Overview
Table 104. Amneal Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 105. Amneal Pharmaceuticals Product
Table 106. Amneal Pharmaceuticals Recent Development
Table 107. Zhejiang Huahai Pharmaceutical Corporation Information
Table 108. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 109. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 110. Zhejiang Huahai Pharmaceutical Product
Table 111. Zhejiang Huahai Pharmaceutical Recent Development
Table 112. Square Pharmaceuticals Corporation Information
Table 113. Square Pharmaceuticals Description and Business Overview
Table 114. Square Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 115. Square Pharmaceuticals Product
Table 116. Square Pharmaceuticals Recent Development
Table 117. Unichem Laboratories Corporation Information
Table 118. Unichem Laboratories Description and Business Overview
Table 119. Unichem Laboratories Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 120. Unichem Laboratories Product
Table 121. Unichem Laboratories Recent Development
Table 122. LG Life Sciences Corporation Information
Table 123. LG Life Sciences Description and Business Overview
Table 124. LG Life Sciences Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2025)
Table 125. LG Life Sciences Product
Table 126. LG Life Sciences Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Valsartan Customers List
Table 130. Valsartan Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Valsartan Product Picture
Figure 2. Global Valsartan Revenue, (US$ Million), 2021 VS 2025 VS 2031
Figure 3. Global Valsartan Market Size 2025-2031 (US$ Million)
Figure 4. Global Valsartan Sales 2025-2031 (K Units)
Figure 5. United States Valsartan Revenue, (US$ Million), 2021 VS 2025 VS 2031
Figure 6. United States Valsartan Market Size 2025-2031 (US$ Million)
Figure 7. United States Valsartan Sales 2025-2031 (K Units)
Figure 8. United States Valsartan Market Share in Global, in Value (US$ Million) 2025-2031
Figure 9. United States Valsartan Market Share in Global, in Volume (K Units) 2025-2031
Figure 10. Valsartan Report Years Considered
Figure 11. Product Picture of 40 mg Tablets
Figure 12. Product Picture of 80 mg Tablets
Figure 13. Product Picture of 160 mg Tablets
Figure 14. Product Picture of 320 mg Tablets
Figure 15. Global Valsartan Market Share by Type in 2025 & 2031
Figure 16. Global Valsartan Sales in Value by Type (2025-2031) & (US$ Million)
Figure 17. Global Valsartan Sales Market Share in Value by Type (2025-2031)
Figure 18. Global Valsartan Sales by Type (2025-2031) & (K Units)
Figure 19. Global Valsartan Sales Market Share in Volume by Type (2025-2031)
Figure 20. Global Valsartan Price by Type (2025-2031) & (US$/Unit)
Figure 21. United States Valsartan Market Share by Type in 2025 & 2031
Figure 22. United States Valsartan Sales in Value by Type (2025-2031) & (US$ Million)
Figure 23. United States Valsartan Sales Market Share in Value by Type (2025-2031)
Figure 24. United States Valsartan Sales by Type (2025-2031) & (K Units)
Figure 25. United States Valsartan Sales Market Share in Volume by Type (2025-2031)
Figure 26. United States Valsartan Price by Type (2025-2031) & (US$/Unit)
Figure 27. Product Picture of Hypertension
Figure 28. Product Picture of Heart Failure
Figure 29. Product Picture of Heart Attack
Figure 30. Global Valsartan Market Share by Application in 2025 & 2031
Figure 31. Global Valsartan Sales in Value by Application (2025-2031) & (US$ Million)
Figure 32. Global Valsartan Sales Market Share in Value by Application (2025-2031)
Figure 33. Global Valsartan Sales by Application (2025-2031) & (K Units)
Figure 34. Global Valsartan Sales Market Share in Volume by Application (2025-2031)
Figure 35. Global Valsartan Price by Application (2025-2031) & (US$/Unit)
Figure 36. United States Valsartan Market Share by Application in 2025 & 2031
Figure 37. United States Valsartan Sales in Value by Application (2025-2031) & (US$ Million)
Figure 38. United States Valsartan Sales Market Share in Value by Application (2025-2031)
Figure 39. United States Valsartan Sales by Application (2025-2031) & (K Units)
Figure 40. United States Valsartan Sales Market Share in Volume by Application (2025-2031)
Figure 41. United States Valsartan Price by Application (2025-2031) & (US$/Unit)
Figure 42. North America Valsartan Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 43. North America Valsartan Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 44. United States Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 45. Canada Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 46. Europe Valsartan Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 47. Europe Valsartan Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 48. Germany Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 49. France Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 50. U.K. Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 51. Italy Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 52. Russia Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 53. Asia-Pacific Valsartan Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 54. Asia-Pacific Valsartan Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 55. China Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 56. Japan Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 57. South Korea Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 58. India Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 59. Australia Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 60. China Taiwan Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 61. Indonesia Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 62. Thailand Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 63. Malaysia Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 64. Latin America Valsartan Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 65. Latin America Valsartan Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 66. Mexico Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 67. Brazil Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 68. Argentina Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 69. Middle East & Africa Valsartan Sales in Volume Growth Rate 2025-2031 (K Units)
Figure 70. Middle East & Africa Valsartan Sales in Value Growth Rate 2025-2031 (US$ Million)
Figure 71. Turkey Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 72. Saudi Arabia Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 73. UAE Valsartan Sales in Value Growth Rate (2025-2031) & (US$ Million)
Figure 74. Valsartan Value Chain
Figure 75. Valsartan Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:

Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.

Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.

Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.

Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.

Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.